Developer docs
API playgroundTry for free, no card

Search company profiles

Cathay Capital Private Equity

Full company profile

uuid000256e

Namestring
Cathay Capital Private Equity
Legal namestring
Cathay Capital Private Equity
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Cathay Capital Private Equity is the principal buyout arm of the Cathay Capital Group, a global multi-stage investment platform founded in 2007 by Mingpo Cai and Edouard Moinet and headquartered in Paris. The firm manages over $5 billion in assets under management across three operating divisions — Cathay Capital Private Equity (small-to-mid-cap buyouts), Cathay Innovation (venture capital, anchored by the recently closed $1B Fund III focused on vertical AI), and Cathay Health (life sciences/healthcare) — and operates from eight offices across Europe, North America, and Asia (Paris, New York, Shanghai, Munich, San Francisco, Beijing, Singapore). The Private Equity division runs two vehicles: a Small Cap growth fund (€250-300M fund size, €15-25M standard check, 72 investments) and a Mid Cap fund (€800M fund size, €50-100M check, 28 investments), targeting companies pursuing cross-border globalization and sustainable digital transformation.

The platform's core "product" is capital plus an ecosystem of more than 20 blue-chip corporate partners — Sanofi, TotalEnergies, Valeo, BNP Paribas Cardif, Groupe SEB, Groupe ADP, L'Oréal, Pernod Ricard, Michelin, Kering, Bpifrance, Accor, Biomerieux, Air Liquide, JCDecaux, Vale and others — that co-invest, provide commercial channels to portfolio companies, and back successive fund vintages. Cathay monetizes through standard private-market economics: recurring management fees on committed/invested capital across PE, VC, and Healthcare vehicles, plus episodic carried interest on investment returns. Distribution is exclusively direct — institutional investor relations, family offices, and corporate LPs accessed through a dedicated IR team and ecosystem network — with no intermediaries or retail channels.

Technology is not the firm's core competency; rather, AI is an explicit investment theme, with Fund III positioned as the largest AI-dedicated VC fund out of the EU and portfolio companies spanning AI-native robotics (THEKER), AI-driven product data management (Equadis), AI drug discovery (AQEMIA, Owkin), AI foundation models for biology (Bioptimus), and AI-enabled fintech (Chime). Supporting services — the Cathay Acceleration Platform (CAP) and Global Operating Partner Program — augment the core funds with talent upgrades, capital-markets guidance, and sector-specific operating expertise.

Short descriptiontext

Cathay Capital Private Equity is the Paris-headquartered buyout arm of Cathay Capital Group, managing over $5 billion AUM through Small Cap and Mid Cap PE funds (plus affiliated Cathay Innovation VC and Cathay Health vehicles), targeting small-to-midsize companies pursuing cross-border growth across Europe, North America, and Asia with backing from a network of blue-chip corporate partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investment, venture capital funding, growth stage capital, healthcare investment, cross-border investment
Industry4 codes
PRIMARYFSANAGAE
Growth Equity Fund-of-Funds
Financial & Insurance/Private Equity & Venture Capital/Fund-of-Funds / Multi-Manager Platforms
SECONDARYFSANACAA
Technology & Software Growth Equity
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity
SECONDARYFSAEALAI
Institutional Capital Introduction (LP/Family Office/Endowment Matching)
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Private Equity & Venture Capital Investment Management
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

Cathay Capital generates revenue through management fees charged on funds under management across its Private Equity, Venture Capital, and Healthcare investment vehicles.

cathaycapital.com
2Carried Interest (Performance Fees)
TypeSubscription Recurring
Description

The firm earns carried interest on investment returns, aligning fund manager incentives with investor returns across Small Cap and Mid Cap Private Equity funds.

cathaycapital.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Cathay Innovation
Description

Venture capital arm investing in startups at the center of digital revolution

cathaycapital.com
+4 more records
Core offering1 text field

Cathay Capital Private Equity operates a global multi-stage investment platform offering private equity, venture capital, and healthcare investment funds. The Private Equity division provides two fund vehicles: the Small Cap Fund (€250-300M, €15-25M check sizes, 72 investments) and Mid Cap Fund (€800M, €50-100M check sizes, 28 investments) for small to midsize companies. Cathay Innovation provides venture capital including Fund III ($1B AI-dedicated), and Cathay Health invests at the convergence of life sciences, healthcare, and technology. Supporting services include the Cathay Acceleration Platform and Global Operating Partner Program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 3-5% increase in online conversion rates, 98% catalog quality and compliance, up to 70% time savings through automation (Equadis portfolio company)
+1 more record
Product overview1 text field

Cathay Capital Private Equity is a global investment platform that operates through multiple distinct products: Cathay Capital (Private Equity) offering two fund vehicles — the Small Cap Fund (€250-300M, €15-25M tickets, 72 investments) and Mid Cap Fund (€800M, €50-100M tickets, 28 investments) investing in small to midsize companies across Europe, North America, and Asia for sustainable digital transformation; Cathay Innovation (Venture Capital) with its €2.5B+ AUM platform including the recently closed $1B Fund III focused on vertical AI; Cathay Health investing at the convergence of life sciences, healthcare, and technology; and supporting services including the Cathay Acceleration Platform (CAP) and Global Operating Partner Program. The portfolio includes product-centric companies such as Equadis (AI-powered product data management SaaS with four integrated modules) and THEKER (AI-native generalist robotics).

Product and service6 records
1Cathay Capital Small Cap Fund (Growth PE)
CategoryPrivate Equity Fund
Description

Growth-stage private equity fund targeting small to midsize companies in Europe, North America, and Asia with €15-25M standard check sizes. The fund supports sustainable digital transformation with 72 investments made to date.

2Cathay Capital Mid Cap Fund (Mid Market PE)
CategoryPrivate Equity Fund
Description

Mid-market private equity fund with €800M fund size and €50-100M investment range. Focuses on North America, Europe, and Asia across healthcare, consumer, business transformation, and financial industries with 28 investments made to date.

3Cathay Innovation Fund III
CategoryVenture Capital Fund
Description

A $1B AI-dedicated venture capital fund investing globally in vertical AI solutions across four key sectors: consumer, healthcare, financial services, and energy/mobility. Named the largest AI-dedicated VC fund out of the European Union.

4Cathay Health
CategoryHealthcare Investment Vertical
Description

Invests globally at the convergence of life sciences, healthcare, and technology, backing companies developing technologies that improve care quality, reduce costs, and enhance patient outcomes. Focus areas include Life Science Tools, Diagnostics, Clinical Trial Innovation, New Care Models, Novel Devices & Materials, and Enabling Technologies for Advanced Therapies.

5Cathay Acceleration Platform (CAP)
CategoryBusiness Acceleration Service
Description

Business resources and consulting support including organizational capability building, talent upgrades, capital market guidance, IPO planning, and business development through ecosystem collaboration and co-investments.

6Global Operating Partner Program
CategoryIndustry Transformation Service
Description

Specialized team of tenured experts bringing practical real-world industrial experience to the Cathay ecosystem, with deep sector expertise in industry/mobility, financial services, healthcare, and agri-food.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

Cathay Capital acquired a majority stake in Equadis, a Swiss SaaS product data management company. The investment supports Equadis' next phase of growth including targeted hiring, international expansion, and AI-driven innovation. Equadis aims to become the European reference in product data management for brands and retailers. Existing shareholders and management team are reinvesting alongside Cathay Capital.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Ardian
TypeDirect peer
Description

Paris-headquartered global PE firm with comparable multi-strategy platform spanning direct PE, fund of funds, infrastructure, and private debt. Closest geographic and structural peer given shared Paris origin, multi-strategy mandate, and similar AUM scale.

TypeDirect peer
Description

Paris-based global investment firm operating across private equity, private debt, and real assets with similar mid-market European focus and cross-border expansion thesis. Comparable in size, structure, and cross-Atlantic-Asia deal flow.

TypeDirect peer
Description

Paris-based mid-market private equity firm focused on European and select global opportunities with similar investment size range. Direct competitor for European mid-cap deals and corporate carve-outs.

TypeDirect peer
Description

Global growth equity investor with comparable multi-region (Americas, Europe, Asia) platform and similar focus on growth-stage and minority/majority transactions. Direct competitor for growth equity deals in technology and consumer.

TypeBroad incumbent
Description

Large global private equity and credit firm with substantially larger AUM operating buyout, growth, and credit strategies across Europe, Asia, and the Americas. Overlaps with Cathay's PE business but at much greater scale and broader mandate.

TypeBroad incumbent
Description

Multi-strategy global alternative asset manager with dedicated private equity, venture (Bain Capital Ventures), and healthcare (Bain Capital Life Sciences) verticals — the closest structural analog to Cathay's PE/VC/Healthcare tripartite model, though at substantially larger AUM.

TypeDirect peer
Description

Global investment firm with European roots operating across private equity and growth equity strategies with comparable check sizes and cross-border deal focus. Direct competitor for mid-market European and global PE transactions.

TypeDirect peer
Description

European-headquartered global private equity firm investing across Europe and North America with comparable mid-to-large cap deal focus. Direct competitor for European mid-market and large-cap buyouts.

TypeBroad incumbent
Description

Multi-strategy alternative asset manager with dedicated Capital, Growth, Impact, and Real Estate platforms. Overlaps with Cathay's growth equity and healthcare investing, particularly at the larger end of the market.

TypeEmerging player
Description

Global growth equity investor focused on software and technology-enabled businesses with similar vertical-AI thesis to Cathay Innovation Fund III. Comparable in growth-stage technology focus and global scope, though more software-concentrated.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment38 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cathay Capital Private Equity

Private Equity & Venture Capital Investment Managementcathaycapital.com

Cathay Capital Private Equity is the Paris-headquartered buyout arm of Cathay Capital Group, managing over $5 billion AUM through Small Cap and Mid Cap PE funds (plus affiliated Cathay Innovation VC and Cathay Health vehicles), targeting small-to-midsize companies pursuing cross-border growth across Europe, North America, and Asia with backing from a network of blue-chip corporate partners.

What Cathay Capital Private Equity does

Cathay Capital Private Equity is the principal buyout arm of the Cathay Capital Group, a global multi-stage investment platform founded in 2007 by Mingpo Cai and Edouard Moinet and headquartered in Paris. The firm manages over $5 billion in assets under management across three operating divisions — Cathay Capital Private Equity (small-to-mid-cap buyouts), Cathay Innovation (venture capital, anchored by the recently closed $1B Fund III focused on vertical AI), and Cathay Health (life sciences/healthcare) — and operates from eight offices across Europe, North America, and Asia (Paris, New York, Shanghai, Munich, San Francisco, Beijing, Singapore). The Private Equity division runs two vehicles: a Small Cap growth fund (€250-300M fund size, €15-25M standard check, 72 investments) and a Mid Cap fund (€800M fund size, €50-100M check, 28 investments), targeting companies pursuing cross-border globalization and sustainable digital transformation.

The platform's core "product" is capital plus an ecosystem of more than 20 blue-chip corporate partners — Sanofi, TotalEnergies, Valeo, BNP Paribas Cardif, Groupe SEB, Groupe ADP, L'Oréal, Pernod Ricard, Michelin, Kering, Bpifrance, Accor, Biomerieux, Air Liquide, JCDecaux, Vale and others — that co-invest, provide commercial channels to portfolio companies, and back successive fund vintages. Cathay monetizes through standard private-market economics: recurring management fees on committed/invested capital across PE, VC, and Healthcare vehicles, plus episodic carried interest on investment returns. Distribution is exclusively direct — institutional investor relations, family offices, and corporate LPs accessed through a dedicated IR team and ecosystem network — with no intermediaries or retail channels.

Technology is not the firm's core competency; rather, AI is an explicit investment theme, with Fund III positioned as the largest AI-dedicated VC fund out of the EU and portfolio companies spanning AI-native robotics (THEKER), AI-driven product data management (Equadis), AI drug discovery (AQEMIA, Owkin), AI foundation models for biology (Bioptimus), and AI-enabled fintech (Chime). Supporting services — the Cathay Acceleration Platform (CAP) and Global Operating Partner Program — augment the core funds with talent upgrades, capital-markets guidance, and sector-specific operating expertise.

Cathay Capital Private Equity firmographics

Firmographics
Name
Cathay Capital Private Equity
Legal name
Cathay Capital Private Equity
Website
https://cathaycapital.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Short description
Cathay Capital Private Equity is the Paris-headquartered buyout arm of Cathay Capital Group, managing over $5 billion AUM through Small Cap and Mid Cap PE funds (plus affiliated Cathay Innovation VC and Cathay Health vehicles), targeting small-to-midsize companies pursuing cross-border growth across Europe, North America, and Asia with backing from a network of blue-chip corporate partners.
Ownership category
akta.pro rank

Cathay Capital Private Equity industry classification

Industry
Product category
Private Equity & Venture Capital Investment Management
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAGAE
Growth Equity Fund-of-Funds
Financial & Insurance/Private Equity & Venture Capital/Fund-of-Funds / Multi-Manager Platforms
SECONDARYFSANACAA
Technology & Software Growth Equity
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity
SECONDARYFSAEALAI
Institutional Capital Introduction (LP/Family Office/Endowment Matching)
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation

Keywords

  • Private equity investment
  • Venture capital funding
  • Growth stage capital
  • Healthcare investment
  • Cross-border investment

Where Cathay Capital Private Equity is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices7 records

Markets served

Cathay Capital Private Equity business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Management Fees: Cathay Capital generates revenue through management fees charged on funds under management across its Private Equity, Venture Capital, and Healthcare investment vehicles.
  2. Carried Interest (Performance Fees): The firm earns carried interest on investment returns, aligning fund manager incentives with investor returns across Small Cap and Mid Cap Private Equity funds.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Cathay Capital Private Equity product offering

Product offering

Core offering

Cathay Capital Private Equity operates a global multi-stage investment platform offering private equity, venture capital, and healthcare investment funds. The Private Equity division provides two fund vehicles: the Small Cap Fund (€250-300M, €15-25M check sizes, 72 investments) and Mid Cap Fund (€800M, €50-100M check sizes, 28 investments) for small to midsize companies. Cathay Innovation provides venture capital including Fund III ($1B AI-dedicated), and Cathay Health invests at the convergence of life sciences, healthcare, and technology. Supporting services include the Cathay Acceleration Platform and Global Operating Partner Program.

Product overview

Cathay Capital Private Equity is a global investment platform that operates through multiple distinct products: Cathay Capital (Private Equity) offering two fund vehicles — the Small Cap Fund (€250-300M, €15-25M tickets, 72 investments) and Mid Cap Fund (€800M, €50-100M tickets, 28 investments) investing in small to midsize companies across Europe, North America, and Asia for sustainable digital transformation; Cathay Innovation (Venture Capital) with its €2.5B+ AUM platform including the recently closed $1B Fund III focused on vertical AI; Cathay Health investing at the convergence of life sciences, healthcare, and technology; and supporting services including the Cathay Acceleration Platform (CAP) and Global Operating Partner Program. The portfolio includes product-centric companies such as Equadis (AI-powered product data management SaaS with four integrated modules) and THEKER (AI-native generalist robotics).

Differentiator

Problem solved

Functional benefit

Brands

  • Cathay Innovation: Venture capital arm investing in startups at the center of digital revolution
  • Cathay Health
  • Cathay Capital Private Equity
  • Small Cap Fund
  • Mid Cap Fund

Products and services

  • Cathay Capital Small Cap Fund (Growth PE) Growth-stage private equity fund targeting small to midsize companies in Europe, North America, and Asia with €15-25M standard check sizes. The fund supports sustainable digital transformation with 72 investments made to date.
  • Cathay Capital Mid Cap Fund (Mid Market PE) Mid-market private equity fund with €800M fund size and €50-100M investment range. Focuses on North America, Europe, and Asia across healthcare, consumer, business transformation, and financial industries with 28 investments made to date.
  • Cathay Innovation Fund III A $1B AI-dedicated venture capital fund investing globally in vertical AI solutions across four key sectors: consumer, healthcare, financial services, and energy/mobility. Named the largest AI-dedicated VC fund out of the European Union.
  • Cathay Health Invests globally at the convergence of life sciences, healthcare, and technology, backing companies developing technologies that improve care quality, reduce costs, and enhance patient outcomes. Focus areas include Life Science Tools, Diagnostics, Clinical Trial Innovation, New Care Models, Novel Devices & Materials, and Enabling Technologies for Advanced Therapies.
  • Cathay Acceleration Platform (CAP) Business resources and consulting support including organizational capability building, talent upgrades, capital market guidance, IPO planning, and business development through ecosystem collaboration and co-investments.
  • Global Operating Partner Program Specialized team of tenured experts bringing practical real-world industrial experience to the Cathay ecosystem, with deep sector expertise in industry/mobility, financial services, healthcare, and agri-food.

Quantifiable outcome

  • 3-5% increase in online conversion rates, 98% catalog quality and compliance, up to 70% time savings through automation (Equadis portfolio company)
  • +1 more outcomes

Companies that use Cathay Capital Private Equity

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Cathay Capital Private Equity technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Cathay Capital Private Equity partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • EquadisflagshipStrategic or Co-development Partner · 16 June 2026Cathay Capital acquired a majority stake in Equadis, a Swiss SaaS product data management company. The investment supports Equadis' next phase of growth including targeted hiring, international expansion, and AI-driven innovation. Equadis aims to become the European reference in product data management for brands and retailers. Existing shareholders and management team are reinvesting alongside Cathay Capital.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Cathay Capital Private Equity competitors and assessment

Company assessment

Direct peers

  • Ardian: Paris-headquartered global PE firm with comparable multi-strategy platform spanning direct PE, fund of funds, infrastructure, and private debt. Closest geographic and structural peer given shared Paris origin, multi-strategy mandate, and similar AUM scale.
  • Eurazeo: Paris-based global investment firm operating across private equity, private debt, and real assets with similar mid-market European focus and cross-border expansion thesis. Comparable in size, structure, and cross-Atlantic-Asia deal flow.
  • PAI Partners: Paris-based mid-market private equity firm focused on European and select global opportunities with similar investment size range. Direct competitor for European mid-cap deals and corporate carve-outs.
  • General Atlantic: Global growth equity investor with comparable multi-region (Americas, Europe, Asia) platform and similar focus on growth-stage and minority/majority transactions. Direct competitor for growth equity deals in technology and consumer.
  • Permira: Global investment firm with European roots operating across private equity and growth equity strategies with comparable check sizes and cross-border deal focus. Direct competitor for mid-market European and global PE transactions.
  • BC Partners: European-headquartered global private equity firm investing across Europe and North America with comparable mid-to-large cap deal focus. Direct competitor for European mid-market and large-cap buyouts.

Broad incumbents

  • CVC Capital Partners: Large global private equity and credit firm with substantially larger AUM operating buyout, growth, and credit strategies across Europe, Asia, and the Americas. Overlaps with Cathay's PE business but at much greater scale and broader mandate.
  • Bain Capital: Multi-strategy global alternative asset manager with dedicated private equity, venture (Bain Capital Ventures), and healthcare (Bain Capital Life Sciences) verticals — the closest structural analog to Cathay's PE/VC/Healthcare tripartite model, though at substantially larger AUM.
  • TPG: Multi-strategy alternative asset manager with dedicated Capital, Growth, Impact, and Real Estate platforms. Overlaps with Cathay's growth equity and healthcare investing, particularly at the larger end of the market.

Emerging players

  • Insight Partners: Global growth equity investor focused on software and technology-enabled businesses with similar vertical-AI thesis to Cathay Innovation Fund III. Comparable in growth-stage technology focus and global scope, though more software-concentrated.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Cathay Capital Private Equity social profiles

Digital presence

Cathay Capital Private Equity financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cathay Capital Private Equity leadership team

Management profile

Number of profiles

Profiles11 records

Cathay Capital Private Equity subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Cathay Capital Private Equity funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cathay Capital Private Equity M&A and investment

M&A and investment

M&A8 records

Investments38 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cathay Capital Private Equity

What does Cathay Capital Private Equity do?

Cathay Capital Private Equity operates a global multi-stage investment platform offering private equity, venture capital, and healthcare investment funds. The Private Equity division provides two fund vehicles: the Small Cap Fund (€250-300M, €15-25M check sizes, 72 investments) and Mid Cap Fund (€800M, €50-100M check sizes, 28 investments) for small to midsize companies. Cathay Innovation provides venture capital including Fund III ($1B AI-dedicated), and Cathay Health invests at the convergence of life sciences, healthcare, and technology. Supporting services include the Cathay Acceleration Platform and Global Operating Partner Program.

Is Cathay Capital Private Equity a public or private company?

Cathay Capital Private Equity is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cathay Capital Private Equity founded?

Cathay Capital Private Equity was founded in 2007. It employs 101 to 250 people.

Where is Cathay Capital Private Equity based?

Cathay Capital Private Equity is headquartered in Paris, France, in the Europe region.

How does Cathay Capital Private Equity make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest (Performance Fees).

Who are Cathay Capital Private Equity's main competitors?

Direct peers on record are Ardian, Eurazeo, PAI Partners, General Atlantic, Permira and BC Partners. Broad incumbents are CVC Capital Partners, Bain Capital and TPG. Insight Partners is listed as an emerging player.

Does Cathay Capital Private Equity have an API?

No public API is recorded for Cathay Capital Private Equity.

What industry is Cathay Capital Private Equity in?

Cathay Capital Private Equity's product category is Private Equity & Venture Capital Investment Management. Its primary akta.pro industry code is FSANAGAE, Growth Equity Fund-of-Funds, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsMoyom Biotech Raises Financing from Cathay CapitalMoyom Biotech, a Shanghai-based regenerative aesthetic biomaterials company, completed a financing round from Cathay Capital's fund. The amount was not disclosed. The company will use the funds to accelerate clinical translation, pursue regulatory approvals, and expand overseas.Venture Capital Access OnlineCathay Capital Invests in Ascendia Autism Care to Expand Access to Evidence-Based ABA Therapy for Children and FamiliesCathay Capital launched Ascendia Autism Care, a platform expanding access to ABA therapy for children with autism. The founding affiliate operates 20 centers across eight states, with plans for new centers in all markets over 24 months. The company will also expand into school-based programs.CathaycapitalCathay Capital Invests in Ascendia Autism Care to Expand Access to Evidence-Based ABA Therapy for Children and FamiliesCathay Capital launched Ascendia Autism Care, a platform expanding access to ABA therapy for children with autism. The founding affiliate operates 20 centers across eight states, with plans for new centers in all markets over 24 months. Financial terms were not disclosed.PandailyVbot Raises ~500M RMB in Pre-A, Debuts Consumer Robot DogVbot raised about 500 million RMB in a Pre-A round, co-led by Oriental Jiafu, Huatai Zijin, and Fosun Ruizheng. Its Vbot Super Robot Dog surpassed 1,000 orders within 52 minutes of its first sale, with cumulative pre-orders reaching 6,540 units by January 10, 2026. The company plans to expand offline stores nationwide by mid-year.MomentaCathay Capital Fund Leads Series B2 Round In Chinese Autonomous Driving Tech Firm MomentaCathay Capital Fund has led the Series B2 funding round for Chinese autonomous driving technology firm Momenta, with participation from GGV Capital. This investment follows a $46 million Series B round completed three months prior and builds upon previous financing from investors including NIO Capital and Sequoia Capital China. The company continues to develop machine vision technologies for self-driving cars and maintains partnerships with major automotive players such as Daimler AG and NIO.Venture Capital Access OnlineCathay Capital Announces Investment in Parkview Dental PartnersCathay Capital has announced an investment in dental service organization Parkview Dental Partners to accelerate its expansion within Florida's $9 billion dental services market. This transaction marks Cathay's inaugural North American investment from its Growth Private Equity Fund (Small Cap IV) and involves equity co-investment from Barings alongside a unitranche credit facility provided by Live Oak Banking Company and Barings.Dentistry TodayCathay Capital Announces Investment in Parkview Dental PartnersPrivate equity firm Cathay Capital has invested in dental service organization Parkview Dental Partners, marking its first North American investment from its Growth Private Equity Fund. The partnership aims to accelerate Parkview's expansion in Florida's fragmented $9 billion dental market through a buy-and-build strategy supported by existing management and co-investors Barings. Live Oak Banking Company provided a unitranche credit facility for the recapitalization transaction.FinSMEsCathay Capital Closes $270M Growth Private Equity FundCathay Capital closed its Small Cap IV growth private equity fund at $270M, backed by global investors. The fund targets 15-20 healthcare, consumer, and technology companies with equity tickets of $15-25M, and has already made six investments including AD Education, Chowsing, and Snocks.PR NewswireCathay Capital Announces Final Close of $270 Million Growth Private Equity FundCathay Capital Private Equity announced the final closing of its $270 million Small Cap IV growth private equity fund, expanding its investment strategy to include North America alongside Europe and Asia. The fund targets 15-20 healthcare, consumer, and technology companies with equity tickets between $15 and $25 million, bringing the firm's total assets under management to $5.5 billion.MarketScreenerEurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre acquired NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.Eurazeo SE, alongside NeoXam's founder and management team, completed the acquisition of NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS on November 24, 2022. Eurazeo invested more than €100 million to become the majority shareholder, with financing supplemented by unitranche debt from Capza and Barings.